Loading...
XASX
MSX
Market cap11mUSD
Nov 19, Last price  
0.04AUD
1D
0.00%
1Q
-33.85%
Name

Mineral Securities Operations Pty Ltd

Chart & performance

D1W1MN
XASX:MSX chart
P/E
—
P/S
—
EPS
Vol. 1Y
102.69%
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Miro Sciences Ltd engages in the research and development of biomedical products targeting neurodegenerative conditions and immune-mediated inflammatory diseases. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. Miro Sciences Ltd was formerly known NeuroScientific Biopharmaceuticals Limited and change its name to Miro Sciences Ltd in October 2026. The company was incorporated in 2002 and is based in Perth, Australia.
URL
IPO date
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

No data to show